1. Home
  2. QNRX vs SLE Comparison

QNRX vs SLE Comparison

Compare QNRX & SLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNRX
  • SLE
  • Stock Information
  • Founded
  • QNRX 2018
  • SLE 2014
  • Country
  • QNRX United States
  • SLE United States
  • Employees
  • QNRX N/A
  • SLE N/A
  • Industry
  • QNRX Medical/Dental Instruments
  • SLE Services-Misc. Amusement & Recreation
  • Sector
  • QNRX Health Care
  • SLE Consumer Discretionary
  • Exchange
  • QNRX Nasdaq
  • SLE Nasdaq
  • Market Cap
  • QNRX 4.8M
  • SLE 5.1M
  • IPO Year
  • QNRX N/A
  • SLE 2019
  • Fundamental
  • Price
  • QNRX $15.56
  • SLE $3.84
  • Analyst Decision
  • QNRX
  • SLE Strong Buy
  • Analyst Count
  • QNRX 0
  • SLE 2
  • Target Price
  • QNRX N/A
  • SLE $100.00
  • AVG Volume (30 Days)
  • QNRX 850.8K
  • SLE 5.3M
  • Earning Date
  • QNRX 11-06-2025
  • SLE 11-13-2025
  • Dividend Yield
  • QNRX N/A
  • SLE N/A
  • EPS Growth
  • QNRX N/A
  • SLE N/A
  • EPS
  • QNRX N/A
  • SLE N/A
  • Revenue
  • QNRX N/A
  • SLE $13,576,000.00
  • Revenue This Year
  • QNRX N/A
  • SLE N/A
  • Revenue Next Year
  • QNRX N/A
  • SLE $28.60
  • P/E Ratio
  • QNRX N/A
  • SLE N/A
  • Revenue Growth
  • QNRX N/A
  • SLE N/A
  • 52 Week Low
  • QNRX $5.01
  • SLE $2.75
  • 52 Week High
  • QNRX $54.95
  • SLE $45.60
  • Technical
  • Relative Strength Index (RSI)
  • QNRX 66.15
  • SLE 48.74
  • Support Level
  • QNRX $12.31
  • SLE $3.70
  • Resistance Level
  • QNRX $41.80
  • SLE $5.12
  • Average True Range (ATR)
  • QNRX 3.40
  • SLE 0.88
  • MACD
  • QNRX 0.95
  • SLE -0.11
  • Stochastic Oscillator
  • QNRX 24.75
  • SLE 7.78

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

Share on Social Networks: